Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Methyldopa - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methyldopa and what is the scope of patent protection?

Methyldopa
is the generic ingredient in three branded drugs marketed by Merck, Sandoz, Watson Labs, Teva, Duramed Pharms Barr, Pliva, Parke Davis, Par Pharm, Ivax Sub Teva Pharms, Purepac Pharm, Halsey, Sun Pharm Inds, Superpharm, Accord Hlthcare, Mylan, Roxane, Marsam Pharms Llc, Smith And Nephew, Hospira, Abraxis Pharm, Teva Parenteral, Luitpold, and Baxter Hlthcare, and is included in fifty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for methyldopa. Ten suppliers are listed for this compound.

Summary for Generic Name: methyldopa

Tradenames:3
Patents:1
Applicants:23
NDAs:57
Drug Master File Entries: see list19
Suppliers / Packagers: see list10
Bulk Api Vendors: see list53
Clinical Trials: see list4
Patent Applications: see list4,892
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methyldopa at DailyMed

Pharmacology for Ingredient: methyldopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
METHYLDOPA
methyldopa
TABLET;ORAL070194-001Apr 25, 1986DISCNNoNo► Subscribe► Subscribe
Halsey
METHYLDOPA
methyldopa
TABLET;ORAL071751-001Mar 28, 1988DISCNNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
METHYLDOPA
methyldopa
TABLET;ORAL070098-001Feb 20, 1986ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
METHYLDOPA
methyldopa
TABLET;ORAL070073-001Oct 9, 1986DISCNNoNo► Subscribe► Subscribe
Accord Hlthcare
METHYLDOPA
methyldopa
TABLET;ORAL070085-001Oct 15, 1985ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot